Ligand Pharmaceuticals Overview
Ligand Pharmaceuticals Target Price
Analysts' 12-month price predictions for LGND.
Share Price
$105.63
Average Target Price
$155.00
46.7% upside
46.7% upside1 analysts in the last 4 months
High: $155 | Low: $155
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-02-28 | UBS | $155 | 46.7% upside |  |
| 2024-10-21 | H.C. WainwrightJoseph Pantginis | $157 | 48.6% upside | |
| 2024-10-02 | OppenheimerLeland Gershell | $135 | 27.8% upside | |
| 2024-07-30 | RBC CapitalDouglas Miehm | $130 | 23.1% upside | |
| 2024-07-09 | Craig-HallumMatt Hewitt | $140 | 32.5% upside | |
| 2024-06-28 | H.C. WainwrightJoseph Pantginis | $144 | 36.3% upside | |
| 2022-12-23 | Roth Capital | $90 |  14.8% downside | |